Literature DB >> 26904558

How much ischemia can the liver tolerate during resection?

Wouter G van Riel1, Rowan F van Golen1, Megan J Reiniers1, Michal Heger1, Thomas M van Gulik1.   

Abstract

The use of vascular inflow occlusion (VIO, also known as the Pringle maneuver) during liver surgery prevents severe blood loss and the need for blood transfusion. The most commonly used technique for VIO entails clamping of the portal triad, which simultaneously occludes the proper hepatic artery and portal vein. Although VIO is an effective technique to reduce intraoperative blood loss, it also inevitably inflicts hepatic ischemia/reperfusion (I/R) injury as a side effect. I/R injury induces formation of reactive oxygen species that cause oxidative stress and cell death, ultimately leading to a sterile inflammatory response that causes hepatocellular damage and liver dysfunction that can result in acute liver failure in most severe cases. Since the duration of ischemia correlates positively with the severity of liver injury, there is a need to find the balance between preventing severe blood loss and inducing liver damage through the use of VIO. Although research on the maximum duration of hepatic ischemia has intensified since the beginning of the 1980s, there still is no consensus on the tolerable upper limit. Based on the available literature, it is concluded that intermittent and continuous VIO can both be used safely when ischemia times do not exceed 120 min. However, intermittent VIO should be the preferred technique in cases that require >120 min duration of ischemia.

Entities:  

Keywords:  Hepatectomy; ischemia; ischemic preconditioning (IP); oxidative stress; reperfusion injury

Year:  2016        PMID: 26904558      PMCID: PMC4739942          DOI: 10.3978/j.issn.2304-3881.2015.07.05

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  62 in total

1.  Safe upper limit of intermittent hepatic inflow occlusion for liver resection in cirrhotic rats.

Authors:  D X Lei; C H Peng; S Y Peng; X C Jiang; Y L Wu; H W Shen
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

2.  Mitochondrial metabolomics unravel the primordial trigger of ischemia/reperfusion injury.

Authors:  Michal Heger; Megan J Reiniers; Rowan F van Golen
Journal:  Gastroenterology       Date:  2015-03-28       Impact factor: 22.682

3.  Safety of hemihepatic vascular occlusion during resection of the liver.

Authors:  M Makuuchi; T Mori; P Gunvén; S Yamazaki; H Hasegawa
Journal:  Surg Gynecol Obstet       Date:  1987-02

Review 4.  The sterile immune response during hepatic ischemia/reperfusion.

Authors:  Rowan F van Golen; Thomas M van Gulik; Michal Heger
Journal:  Cytokine Growth Factor Rev       Date:  2012-05-17       Impact factor: 7.638

5.  Continuous versus intermittent portal triad clamping for liver resection: a controlled study.

Authors:  J Belghiti; R Noun; R Malafosse; P Jagot; A Sauvanet; F Pierangeli; J Marty; O Farges
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

6.  Comparison of continuous versus intermittent hepatic pedicle clamping in an experimental model.

Authors:  A Chiappa; M Makuuchi; A P Zbar; F Biella; A Vezzoni; S Pozzi; B Andreoni
Journal:  Hepatogastroenterology       Date:  2001 Sep-Oct

7.  Tolerance of the human liver to prolonged normothermic ischemia. A biological study of 20 patients submitted to extensive hepatectomy.

Authors:  C Huguet; B Nordlinger; P Bloch; J Conard
Journal:  Arch Surg       Date:  1978-12

8.  Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: no impact on survival or hepatic recurrence.

Authors:  Matthew J Weiss; Hiromichi Ito; Raphael L C Araujo; Emily C Zabor; Mithat Gonen; Michael I D'Angelica; Peter J Allen; Ronald P DeMatteo; Yuman Fong; Leslie H Blumgart; William R Jarnagin
Journal:  Ann Surg Oncol       Date:  2012-08-07       Impact factor: 5.344

Review 9.  Vascular occlusion for elective liver resections.

Authors:  Kurinchi Selvan Gurusamy; Yogesh Kumar; Rajarajan Ramamoorthy; Dinesh Sharma; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

10.  Prolonged intermittent clamping of the portal triad during hepatectomy.

Authors:  D Elias; E Desruennes; P Lasser
Journal:  Br J Surg       Date:  1991-01       Impact factor: 6.939

View more
  28 in total

1.  Postoperative peak transaminases correlate with morbidity and mortality after liver resection.

Authors:  Pim B Olthof; Joost Huiskens; Niek R Schulte; Dennis A Wicherts; Marc G Besselink; Olivier R Busch; Michal Heger; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2016-09-02       Impact factor: 3.647

2.  TSLP protects against liver I/R injury via activation of the PI3K/Akt pathway.

Authors:  Shilai Li; Zhongjie Yi; Meihong Deng; Melanie J Scott; Chenxuan Yang; Wenbo Li; Zhao Lei; Nicole M Santerre; Patricia Loughran; Timothy R Billiar
Journal:  JCI Insight       Date:  2019-11-14

3.  How Much Ischemia Can the Severely Steatotic Rat Liver Tolerate?

Authors:  Ioannis D Kostakis; Nikolaos Sikalias; Konstantinos Alexiou; Lamprini Mountzalia; Apostolos Papalois; Theodore Karatzas
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

4.  Interpatient heterogeneity in hepatic microvascular blood flow during vascular inflow occlusion (Pringle manoeuvre).

Authors:  Lucinda Shen; Zühre Uz; Joanne Verheij; Denise P Veelo; Yasin Ince; Can Ince; Thomas M van Gulik
Journal:  Hepatobiliary Surg Nutr       Date:  2020-06       Impact factor: 7.293

Review 5.  Relevance of Endoplasmic Reticulum Stress Cell Signaling in Liver Cold Ischemia Reperfusion Injury.

Authors:  Emma Folch-Puy; Arnau Panisello; Joan Oliva; Alexandre Lopez; Carlos Castro Benítez; René Adam; Joan Roselló-Catafau
Journal:  Int J Mol Sci       Date:  2016-05-25       Impact factor: 5.923

6.  Use of the liver maximum function capacity test (LiMAx) for the management of liver resection in cirrhosis - A case of hypopharyngeal cancer liver metastasis.

Authors:  S Cammann; F Oldhafer; K I Ringe; W Ramackers; K Timrott; M Kleine; J Klempnauer; F Lehner; H Bektas; F W R Vondran
Journal:  Int J Surg Case Rep       Date:  2017-08-10

7.  One-stage laparoscopic parenchymal sparing liver resection for bilobar colorectal liver metastases: safety, recurrence patterns and oncologic outcomes.

Authors:  Mathieu D'Hondt; Zoë Pironet; Isabelle Parmentier; Celine De Meyere; Marc Besselink; Hans Pottel; Franky Vansteenkiste; Chris Verslype
Journal:  Surg Endosc       Date:  2021-03-08       Impact factor: 4.584

8.  Perivascular vital cells in the ablation center after multibipolar radiofrequency ablation in an in vivo porcine model.

Authors:  F G M Poch; C A Neizert; B Geyer; O Gemeinhardt; S M Niehues; J L Vahldiek; K K Bressem; K S Lehmann
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

Review 9.  Computational Modeling in Liver Surgery.

Authors:  Bruno Christ; Uta Dahmen; Karl-Heinz Herrmann; Matthias König; Jürgen R Reichenbach; Tim Ricken; Jana Schleicher; Lars Ole Schwen; Sebastian Vlaic; Navina Waschinsky
Journal:  Front Physiol       Date:  2017-11-14       Impact factor: 4.566

10.  Brg1-mediated Nrf2/HO-1 pathway activation alleviates hepatic ischemia-reperfusion injury.

Authors:  Mian Ge; Weifeng Yao; Dongdong Yuan; Shaoli Zhou; Xi Chen; Yihan Zhang; Haobo Li; Zhengyuan Xia; Ziqing Hei
Journal:  Cell Death Dis       Date:  2017-06-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.